Trials / Completed
CompletedNCT07190105
Vagal Approaches on Long COVID-19
Impact of Vagal Approaches on Symptomatology in Long COVID Participants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 546 (actual)
- Sponsor
- Leidos Life Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore whether two general wellness products, alone or combined, can support individuals experiencing Long COVID symptoms. Both wellness products stimulate the vagus nerve - a nerve that helps regulate stress, relaxation, mood, breathing, heart rate, inflammation, and digestion. The investigators will use a Fitbit to track participants' health measurements including, but not limited to, activity, heart rate, and heart rate variability, and participants will be asked to complete surveys about their experience. This information will be collected into a repository where participants can share their experiences with Long COVID symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sonocea Sonic Augmentation Technology (SAT) | The Sonocea Sonic Augmentation Technology (SAT) is a sound-based approach delivered via headphones through a smartphone application. The approach uses music soundscapes that have been standardized in format, intensity and duration. |
| OTHER | Truvaga Electrical Vagus Nerve Stimulator | The Truvaga Electrical Vagus Nerve Stimulator is a general wellness product that sends gentle electrical signals through the skin to stimulate the vagus nerve on the neck. |
Timeline
- Start date
- 2025-10-27
- Primary completion
- 2025-12-11
- Completion
- 2025-12-11
- First posted
- 2025-09-24
- Last updated
- 2026-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07190105. Inclusion in this directory is not an endorsement.